title: Modulators of the microRNA biogenesis pathway via arrayed lentiviral enabled RNAi screening for drug and biomarker discovery.
abstract: MicroRNAs (miRNAs) are small endogenous and conserved non-coding RNA molecules that regulate gene expression. Although the first miRNA was discovered well over sixteen years ago, little is known about their biogenesis and it is only recently that we have begun to understand their scope and diversity. For this purpose, we performed an RNAi screen aimed at identifying genes involved in their biogenesis pathway with a potential use as biomarkers. Using a previously developed miRNA 21 (miR-21) EGFP-based biosensor cell based assay monitoring green fluorescence enhancements, we performed an arrayed short hairpin RNA (shRNA) screen against a lentiviral particle ready TRC1 library covering 16,039 genes in 384-well plate format, and interrogating the genome one gene at a time building a panoramic view of endogenous miRNA activity. Using the BDA method for RNAi data analysis, we nominate 497 gene candidates the knockdown of which increased the EGFP fluorescence and yielding an initial hit rate of 3.09%; of which only 22, with reported validated clones, are deemed high-confidence gene candidates. An unexpected and surprising result was that only DROSHA was identified as a hit out of the seven core essential miRNA biogenesis genes; suggesting that perhaps intracellular shRNA processing into the correct duplex may be cell dependent and with differential outcome. Biological classification revealed several major control junctions among them genes involved in transport and vesicular trafficking. In summary, we report on 22 high confidence gene candidate regulators of miRNA biogenesis with potential use in drug and biomarker discovery.
authors: HTS Core Facility, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. djaballh@mskcc.org.
authors: David
authors: D
authors: Shum
authors: Bhavneet
authors: B
authors: Bhinder
authors: Hakim
authors: H
authors: Djaballah
mesh_terms: D015415:Biomarkers / Q000032:analysis*; D055808:Drug Discovery; D016086:Lentivirus / Q000235:genetics*; D035683:MicroRNAs / Q000096:biosynthesis* / Q000235:genetics; D034622:RNA Interference
chemical_list: D015415:Biomarkers; D035683:MicroRNAs
references: Cancer Biol Ther. 2013 Mar;14(3):201-12
references: 23291983
references: Genome Biol. 2004;5(3):R13
references: 15003116
references: Nat Struct Mol Biol. 2006 Jan;13(1):13-21
references: 16369484
references: J Biol Chem. 2010 Aug 13;285(33):25221-31
references: 20551325
references: Trends Cell Biol. 2010 Aug;20(8):491-501
references: 20630759
references: Cancer Res. 2011 Jul 1;71(13):4720-31
references: 21555366
references: Cell Biol Int. 2013 Jul;37(7):669-74
references: 23483606
references: Comb Chem High Throughput Screen. 2012 Aug;15(7):529-41
references: 22540737
references: Cold Spring Harb Symp Quant Biol. 2006;71:51-7
references: 17381280
references: EMBO Mol Med. 2012 Mar;4(3):143-59
references: 22351564
references: Annu Rev Biochem. 1993;62:289-321
references: 8352591
references: Adv Drug Deliv Rev. 2009 Jul 25;61(9):732-45
references: 19341774
references: Nat Genet. 2009 Mar;41(3):365-70
references: 19219043
references: Dev Cell. 2003 Aug;5(2):351-8
references: 12919684
references: Genes Dev. 2003 Dec 15;17(24):3011-6
references: 14681208
references: Nature. 2004 Nov 11;432(7014):235-40
references: 15531877
references: FEBS Lett. 2008 Dec 10;582(29):4107-11
references: 19026641
references: Mol Ther. 2013 Jan;21(1):217-27
references: 23089734
references: Mol Cell Biol. 2009 Nov;29(21):5789-99
references: 19704008
references: Assay Drug Dev Technol. 2013 Apr;11(3):191-205
references: 23153064
references: Cancer Cell. 2006 Mar;9(3):189-98
references: 16530703
references: Biophys J. 2004 Feb;86(2):1234-42
references: 14747357
references: Nat Methods. 2006 Sep;3(9):715-9
references: 16929317
references: Oncoimmunology. 2012 Aug 1;1(5):746-748
references: 22934269
references: Comb Chem High Throughput Screen. 2012 Nov;15(9):686-704
references: 22934950
references: Dev Cell. 2006 Oct;11(4):441-50
references: 17011485
references: Cell. 1993 Dec 3;75(5):843-54
references: 8252621
references: EMBO J. 2006 Feb 8;25(3):522-32
references: 16424907
references: Assay Drug Dev Technol. 2013 Apr;11(3):173-90
references: 23198867
references: Mol Cancer. 2011 Nov 03;10:135
references: 22051041
references: Genes Dev. 2004 Jul 15;18(14):1655-66
references: 15231716
references: Biochem Biophys Res Commun. 2013 Feb 15;431(3):404-8
references: 23333386
references: Br J Cancer. 2012 Feb 28;106(5):867-75
references: 22333600
references: Cell. 2009 Oct 2;139(1):112-22
references: 19804757
references: Trends Biochem Sci. 2008 Oct;33(10):474-81
references: 18774719
references: Nature. 2003 Sep 25;425(6956):415-9
references: 14508493
references: Nature. 2005 Aug 4;436(7051):740-4
references: 15973356
references: Curr Genomics. 2010 May;11(3):162-7
references: 21037854
references: Genes Dev. 2004 Dec 15;18(24):3016-27
references: 15574589
references: J Cyst Fibros. 2013 Dec;12(6):797-802
references: 23632450
references: Cell. 2004 Jan 23;116(2):281-97
references: 14744438
references: J Cell Biol. 2006 Jun 5;173(5):767-80
references: 16754960
references: Trends Cell Biol. 2006 Oct;16(10):522-9
references: 16949823